Physician profile
Sherley Aramath
NPI 1043449325
$1,955.68
in general payments reported to CMS, 2019-2025
20 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $117 · 2022: $195 · 2023: $499 · 2024: $469 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $408.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $384.76 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $250.46 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $109.67 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.00 | 2019-2023 | Jardiance |
| Pfizer INC. | $103.12 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $102.21 | 2019-2025 | Vaqta, Gardasil 9, Capvaxive |
| Abbott Laboratories | $85.67 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Medtronic USA, INC. | $77.70 | 2019 | |
| Amarin Pharma, INC. | $75.72 | 2019-2022 | |
| Sonex Health, INC. | $48.05 | 2023 | Sx-One Microknife |
| Sanofi Pasteur INC. | $39.44 | 2022-2023 | |
| Hologic Sales and Service, LLC | $34.42 | 2019-2025 | Aptima |
| Abbvie INC. | $32.32 | 2019-2023 | Vraylar |
| Kowa Pharmaceuticals America, INC. | $23.60 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $19.11 | 2023 | Heplisav-B |
| Mission Pharmacal Company | $16.51 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.38 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $12.89 | 2023 | Prehevbrio |
| Arbor Pharmaceuticals, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherley Aramath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.